company background image
000623 logo

Jilin Aodong Pharmaceutical Group SZSE:000623 Stock Report

Last Price

CN¥17.87

Market Cap

CN¥21.5b

7D

-0.7%

1Y

19.1%

Updated

25 Dec, 2024

Data

Company Financials

Jilin Aodong Pharmaceutical Group Co., Ltd.

SZSE:000623 Stock Report

Market Cap: CN¥21.5b

My Notes

Capture your thoughts, links and company narrative

Jilin Aodong Pharmaceutical Group Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Jilin Aodong Pharmaceutical Group
Historical stock prices
Current Share PriceCN¥17.87
52 Week HighCN¥19.98
52 Week LowCN¥12.49
Beta0.49
1 Month Change-2.30%
3 Month Change20.99%
1 Year Change19.05%
3 Year Change0.28%
5 Year Change8.11%
Change since IPO484.28%

Recent News & Updates

We Think That There Are More Issues For Jilin Aodong Pharmaceutical Group (SZSE:000623) Than Just Sluggish Earnings

Nov 06
We Think That There Are More Issues For Jilin Aodong Pharmaceutical Group (SZSE:000623) Than Just Sluggish Earnings

Market Might Still Lack Some Conviction On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623) Even After 36% Share Price Boost

Oct 01
Market Might Still Lack Some Conviction On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623) Even After 36% Share Price Boost

Recent updates

We Think That There Are More Issues For Jilin Aodong Pharmaceutical Group (SZSE:000623) Than Just Sluggish Earnings

Nov 06
We Think That There Are More Issues For Jilin Aodong Pharmaceutical Group (SZSE:000623) Than Just Sluggish Earnings

Market Might Still Lack Some Conviction On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623) Even After 36% Share Price Boost

Oct 01
Market Might Still Lack Some Conviction On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623) Even After 36% Share Price Boost

A Look At The Intrinsic Value Of Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)

Aug 22
A Look At The Intrinsic Value Of Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)

Jilin Aodong Pharmaceutical Group (SZSE:000623) Is Increasing Its Dividend To CN¥0.60

Jul 05
Jilin Aodong Pharmaceutical Group (SZSE:000623) Is Increasing Its Dividend To CN¥0.60

Investors Holding Back On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)

Jun 03
Investors Holding Back On Jilin Aodong Pharmaceutical Group Co., Ltd. (SZSE:000623)

There Might Be More To Jilin Aodong Pharmaceutical Group's (SZSE:000623) Story Than Just Weak Earnings

Apr 23
There Might Be More To Jilin Aodong Pharmaceutical Group's (SZSE:000623) Story Than Just Weak Earnings

Shareholder Returns

000623CN PharmaceuticalsCN Market
7D-0.7%-1.0%0.4%
1Y19.1%-3.0%12.3%

Return vs Industry: 000623 exceeded the CN Pharmaceuticals industry which returned -3% over the past year.

Return vs Market: 000623 exceeded the CN Market which returned 12.3% over the past year.

Price Volatility

Is 000623's price volatile compared to industry and market?
000623 volatility
000623 Average Weekly Movement6.5%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.8%
10% most volatile stocks in CN Market13.0%
10% least volatile stocks in CN Market5.8%

Stable Share Price: 000623 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 000623's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19575,646Shuqin Guowww.jlaod.com

Jilin Aodong Pharmaceutical Group Co., Ltd. produces and sells pharmaceutical products in China. The company offers various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine.

Jilin Aodong Pharmaceutical Group Co., Ltd. Fundamentals Summary

How do Jilin Aodong Pharmaceutical Group's earnings and revenue compare to its market cap?
000623 fundamental statistics
Market capCN¥21.48b
Earnings (TTM)CN¥1.43b
Revenue (TTM)CN¥3.00b

14.9x

P/E Ratio

7.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
000623 income statement (TTM)
RevenueCN¥3.00b
Cost of RevenueCN¥1.76b
Gross ProfitCN¥1.24b
Other Expenses-CN¥188.49m
EarningsCN¥1.43b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.20
Gross Margin41.31%
Net Profit Margin47.58%
Debt/Equity Ratio7.3%

How did 000623 perform over the long term?

See historical performance and comparison

Dividends

2.2%

Current Dividend Yield

65%

Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 15:59
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jilin Aodong Pharmaceutical Group Co., Ltd. is covered by 7 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Weina JiangEverbright Securities Co. Ltd.
Lei PanGuodu Securities Co.
null Research DepartmentGuotai Junan International Holdings Limited